A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Researchers at the University of Michigan have developed DT-109, a compound that reduces fatty liver disease and ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...